Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polonsky

Showing results (411-420 of 850) with videos related to

Pageof 85
Sort By:
Obesity Science & Practice|October 27, 2017
Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherenceG S Carls, R Tan, J Y Zhu, et al.
BMC Infectious Diseases|January 30, 2022
Sensitivity of contact-tracing for COVID-19 in Thailand: a capture-recapture applicationR Lerdsuwansri, P Sangnawakij, D Böhning, et al.
Population Health Metrics|September 6, 2012
Sentinel site community surveillance of mortality and nutritional status in southwestern Central African Republic, 2010Grazia M Caleo, Aly Penda Sy, Serge Balandine, et al.
Diabetes|November 14, 1997
Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 geneW H Herman, S S Fajans, M J Smith, et al.
Primary Care Diabetes|November 23, 2021
A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetesAaisha Farooqi, Clare Gillies, Harini Sathanapally, et al.
Journal of Diabetes Science and Technology|April 16, 2016
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982
Surface receptors for pancreatic hormones in dog and rat hepatocytes: qualitative and quantitative differences in hormone-target cell interactionsV Bonnevie-Nielsen, K S Polonsky, J J Jaspan, et al.
Diabetes|November 26, 2009
TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin actionDennis T Villareal, Heather Robertson, Graeme I Bell, et al.
Diabetes Care|August 13, 2017
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 DiabetesGinger S Carls, Edward Tuttle, Ruo-Ding Tan, et al.
Journal of the American Heart Association|March 13, 2019
Prognostic Importance of Defibrillator-Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart FailureYitschak Biton, Usama A Daimee, Jayson R Baman, et al.
Pageof 85

Showing results (411-420 of 850) with videos related to

Sort By:
Pageof 85
Obesity Science & Practice|October 27, 2017
Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherenceG S Carls, R Tan, J Y Zhu, et al.
BMC Infectious Diseases|January 30, 2022
Sensitivity of contact-tracing for COVID-19 in Thailand: a capture-recapture applicationR Lerdsuwansri, P Sangnawakij, D Böhning, et al.
Population Health Metrics|September 6, 2012
Sentinel site community surveillance of mortality and nutritional status in southwestern Central African Republic, 2010Grazia M Caleo, Aly Penda Sy, Serge Balandine, et al.
Diabetes|November 14, 1997
Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 geneW H Herman, S S Fajans, M J Smith, et al.
Primary Care Diabetes|November 23, 2021
A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetesAaisha Farooqi, Clare Gillies, Harini Sathanapally, et al.
Journal of Diabetes Science and Technology|April 16, 2016
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982
Surface receptors for pancreatic hormones in dog and rat hepatocytes: qualitative and quantitative differences in hormone-target cell interactionsV Bonnevie-Nielsen, K S Polonsky, J J Jaspan, et al.
Diabetes|November 26, 2009
TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin actionDennis T Villareal, Heather Robertson, Graeme I Bell, et al.
Diabetes Care|August 13, 2017
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 DiabetesGinger S Carls, Edward Tuttle, Ruo-Ding Tan, et al.
Journal of the American Heart Association|March 13, 2019
Prognostic Importance of Defibrillator-Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart FailureYitschak Biton, Usama A Daimee, Jayson R Baman, et al.
Pageof 85